The adrenogenital syndrome is one of the most frequent metabolic diseases. This disorder of adrenal biosynthesis can now be classified unequivocally on the basis of molecular biological techniques. In its classical form, this disease is characterized by loss of the gene region which codes for adrenal 21-hydroxylase. The techniques of gene analysis enable unequivocal identification of carriers of heterozygotic and homozygotic features and hence affords the basis for a rational concept for therapy of this disease.
|Translated title of the contribution||Molecular biology of the adrenogenital syndrome. New possibilities of heterozygote screening|
|Number of pages||3|
|Journal||Deutsche Medizinische Wochenschrift|
|State||Published - Feb 27 1987|
ASJC Scopus subject areas